Virus-like particles: flexible platforms for vaccine development.
about
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal modelA virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionRecent vaccine technology in industrial animalsCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assembliesBivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virusPreclinical efficacy of a virus-like particle-based vaccine against avian influenza H5N1Versatile virus-like particle carrier for epitope based vaccinesImmunogenicity of H1N1 influenza virus-like particles produced in Nicotiana benthamiana.EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD).Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedlesViral vaccines for farmed finfishAntigen vehiculization particles based on the Z protein of Junin virus.Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.Vaccine potential of Nipah virus-like particlesPeptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.A hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly.Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizingConstruction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation.Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway.Bacterial superglue enables easy development of efficient virus-like particle based vaccines.Optimization of multimeric human papillomavirus L2 vaccines.Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.Exploiting viral properties for the rational design of modern vaccines.Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding proteinStructural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodiesThe use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine.Second-generation prophylactic HPV vaccines: successes and challenges.Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platformMammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory TractInduction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform.A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA.
P2860
Q21131365-2E70CCC0-921C-4348-A1A9-B0972679EE27Q24631774-C025D0E8-6A5D-482A-8E3D-4322692EBC55Q26766625-CC91EBA8-8629-474B-BFF3-E7FE0E40AC98Q26830028-323E27F2-C23A-4A02-8A98-8F00760E13D1Q26858808-39D72617-DC94-45E9-9528-A42DFCFA799AQ27469019-F723AE03-823D-486F-898A-B03B292125AEQ28247277-B4773F60-30AA-4F14-9149-5A24C11202F2Q28748358-B566D764-3C16-44D3-8132-88D839E0A588Q30369470-58CC1138-E136-4CA8-9F63-53A9084B28F7Q30383172-66B1A8C1-D6DD-4494-A6F0-C1F08D3480BAQ30387699-D1B027BA-C025-4B38-8A9D-9499BBC96B75Q30395028-FD712EDD-182A-4E4B-8576-C7859E9F2AB3Q30402208-1761543A-BD60-4F8C-8593-9A8F17DD7CD1Q30564097-0EE6286C-C6E4-4C8B-AF82-37FD986089D1Q31106232-993BD6AE-9C5E-471A-A67D-427895B80197Q33569555-551F1F61-B8BF-4F29-9F10-3956E2618AE3Q33677615-8EE77663-3113-4842-8B84-DDB9EBBA0ABFQ33873756-71EEAC8B-3035-4510-9907-CB7936CC3B3CQ33876044-F655ACD2-C1A3-430D-B422-A8BF80B10517Q33876183-344F554D-B9EB-4E27-BDAA-AA490D95115BQ33918642-87217E92-B7BF-4327-81E0-6682F17133BCQ33967341-331AECE1-7CA8-4F6F-A979-DF756C42F412Q34416974-B36155BE-B834-4214-9032-1CB208975DB2Q34472793-BA97D2B3-3374-4E7C-BC89-983ECC8CFB35Q34523734-09CF000A-6E06-4683-AFF1-BB7851F59B00Q34576677-C5653764-46D3-4B3F-B0AC-E9D0F4B38DA5Q34608302-00545377-63AB-45D7-AA26-03FAD29CEEB0Q34746139-D13538B4-194A-4644-B823-B4B99BFCBDCFQ34746490-3F7B029E-1F4D-4B33-BCAE-4F03A26160C4Q34994491-C89DC7FC-93AB-4B92-AF46-AEDDCCE29271Q35076683-9153C691-DD70-4374-9190-71988446F94FQ35151690-327BEDC6-0471-4EC8-A4D0-9EB35468AAFEQ35456892-2F9AE493-DB07-4D4C-B109-84E8EF79A5AEQ35541210-8DD67B2E-3013-466B-855D-CB87EE35D627Q35541886-E64B66B7-4719-403D-810B-48473D6C57F2Q35591551-D6BEDCE8-0D20-4AB8-9C9E-E43A918FA2F9Q35690781-EC1BEA4B-95AA-4C90-9B4E-0ED5EAA3FCACQ35772032-2D0A8315-2B05-49B9-A16E-41EEE3F4673CQ35827034-5247BEC3-36F0-40CB-ACCC-8BE15ED04478Q35850159-9787CD3B-D1AC-4E91-AD41-E7552171C5B1
P2860
Virus-like particles: flexible platforms for vaccine development.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Virus-like particles: flexible platforms for vaccine development.
@en
type
label
Virus-like particles: flexible platforms for vaccine development.
@en
prefLabel
Virus-like particles: flexible platforms for vaccine development.
@en
P2860
P356
P1476
Virus-like particles: flexible platforms for vaccine development.
@en
P2093
Bryce Chackerian
P2860
P304
P356
10.1586/14760584.6.3.381
P577
2007-06-01T00:00:00Z